A Phase 3 trial failure has erased a year of gains for Ionis Pharmaceuticals in just days, and the ripple effects are rattling rivals across the RNA and rare-disease biotech space with more catalysts…
One brutal week and one chaotic Thursday left Rackspace investors staring at a guidance cut, a shareholder investigation, and a last-minute AI gamble with Palantir. Now the stock is bouncing hard, and the question…
SanDisk went vertical and you watched from the sidelines. Before you spiral into regret, consider what most people overlook: missing the stock does not mean you missed the trade.
Space stocks have been getting crushed over the past month, with some names down 40% or more, yet one company managed to shrug off the carnage entirely. The reason why says a lot about…
Hyperscalers are posting record capital expenditures while free cash flow craters, yet Microsoft, Amazon, and Alphabet insist every data center is already sold before the first server goes in. A top Wall Street analyst…
Micron just shattered records and minted fortunes, but if you skipped it entirely, your portfolio may have caught more of that wave than you think.
The US-Iran ceasefire is fracturing, Brent is climbing, and energy stocks are repricing fast. Whether this is a temporary spike or the beginning of a sustained oil shock will reshape the Fed's next move…
A rule change quietly reshaping who can day trade in America just handed Webull a potential unlock that most investors have not priced in yet, and the window to act ahead of the market…
Jim Cramer just made his first bearish call in 25 years, and the trigger was not a market crash or a recession signal but a bond deal and a record-breaking equity offering that he…
Jim Cramer says the SK Hynix mega-listing clears the biggest threat hanging over AI stocks in 2026, but one scenario could blow that thesis apart before summer ends.
Every quarter, one chipmaker hands its shareholders a stronger reason to own it than the previous quarter, and most investors are still scanning the wrong names for AI exposure.
A tech CEO argues that critics of AI are failing to weigh both sides of a historic shift, one that could eliminate cancer, reinvent education, and rewrite the rules of scarcity. The bottleneck standing…
Abbott and Danaher both reported Q1 2026 results, but the businesses underneath those numbers point in opposite directions, and choosing the wrong one right now costs more than just a few percentage points of…
Everyone is posting screenshots of the AI stock that tripled this year, and you never touched it. But your portfolio may have captured far more of that move than you realize, without the volatility…
Oklo crashed from nearly $200 to a 52-week low while its operational milestones kept piling up, creating a gap between price action and reality that our model says the market has badly mispriced.
